![Nathan Fischel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan Fischel
Director/Board Member at
STEREOTAXIS, INC.
Net worth: 908 177 $ as of 2026-07-30
Profile
Dr. Nathan Fischel is a Chief Executive Officer & Founder at DAFNA Capital Management LLC.
He is on the Board of Directors at Stereotaxis, Inc.
Dr. Fischel was previously employed as a Director-Molecular Hematology by Cedars-Sinai Medical Center and a Professor by David Geffen School of Medicine.
He received his doctorate degree from Technion-Israel Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
STEREOTAXIS, INC. 0.74% | 2026-06-30 | 720,775 ( 0.74% ) | 908 177 $ | 2026-07-30 |
Nathan Fischel active positions
| Companies | Position | Start |
|---|---|---|
| STEREOTAXIS, INC. | Director/Board Member | 2017-02-02 |
DAFNA Capital Management LLC
 DAFNA Capital Management LLC Investment ManagersFinance DAFNA Capital employs fundamental analysis and event-driven strategies to make long and short investments in publicly traded biotechnology and medical device companies. The firm seeks capital preservation and strong annualized return over longer time periods with minimum risk. Investment returns are generated as a product of recognizing their responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions. The majority of their investments are in small/mid-cap companies with a focused pipeline or business and are based in the US or other developed countries. | Chief Executive Officer | 1998-12-31 |
Former positions of Nathan Fischel
| Companies | Position | End |
|---|---|---|
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Nathan Fischel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Stereotaxis, Inc.
 Stereotaxis, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets robotic cardiology instrument navigation systems | Health Technology |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
DAFNA Capital Management LLC
DAFNA Capital Management LLC Investment ManagersFinance DAFNA Capital employs fundamental analysis and event-driven strategies to make long and short investments in publicly traded biotechnology and medical device companies. The firm seeks capital preservation and strong annualized return over longer time periods with minimum risk. Investment returns are generated as a product of recognizing their responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions. The majority of their investments are in small/mid-cap companies with a focused pipeline or business and are based in the US or other developed countries. | Finance |
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Nathan Fischel
